Raising The Bar For Anticoagulants? Warfarin Genotype Results Announced

Results of a prospective observational study conducted by the pharmacy benefit manager Medco and the Mayo Clinic link more precise warfarin dosing through genotyping to a 30 percent reduction in hospitalization rates from any cause within six months of starting the drug